Pilot Study of Remote Glucose Monitoring Among Pediatric Patients With Type 1 Diabetes
- Conditions
- Type 1 Diabetes
- Interventions
- Behavioral: Remote Patient Monitoring
- Registration Number
- NCT04696640
- Lead Sponsor
- University of California, Davis
- Brief Summary
This project explores the feasibility and utility of remote glucose monitoring for a cohort of children and adolescents with type 1 diabetes (T1D) cared for at UC Davis Health (UCDH).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 39
- Diagnoses of type 1 diabetes with a duration of greater than or equal to 12 months
- Use of a continuous glucose monitor (CGM) for greater than or equal to 6 months
- Intention to continue receiving care at the UC Davis Health Pediatric Diabetes clinic.
- Patient's CGM cannot be uploaded to Glooko
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description Remote Patient Monitoring Remote Patient Monitoring All participants who have successfully established remote data-sharing from their glucose monitors to the research team's Glooko account by conclusion of the one-month baseline period will advance to the six-month intervention period.
- Primary Outcome Measures
Name Time Method Feasibility of remote glucose monitoring for pediatric T1D patients who receive care at UC Davis Health 1 month baseline period Proportion of participants who have successfully established remote glucose monitoring by the end of the baseline period.
Change in hemoglobin A1c (HbA1c) Initiation = 1 month after enrollment, Study completion = 7 months after enrollment HbA1c at study completion minus the HbA1c at initiation
- Secondary Outcome Measures
Name Time Method Remote patient monitoring survey Month 7 after enrollment Survey asking about patient's experience with remote patient monitoring
Hyperglycemic range Months 1-7 after enrollment Percentage of time spent in hyperglycemic range (generated from continuous glucose monitor)
Hypoglycemic range Months 1-7 after enrollment Percentage of time spent in hypoglycemic range (generated from continuous glucose monitor)
Target Glucose Range Months 1-7 after enrollment Percentage of time spent in target glucose range (generated from continuous glucose monitor)
Overall continuous glucose monitor (CGM) wear time Months 1-7 after enrollment Percentage of time spent wearing continuous glucose monitor (generated from continuous glucose monitor)
Data-sharing experience survey 1 month after enrollment Survey asking about patient's experience with data-sharing
Trial Locations
- Locations (1)
University of California-Davis
🇺🇸Sacramento, California, United States